Search Results - Daniel Cho

798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update by Aaron Scott, Manish Patel, Julie Bauman, Jeffrey Clarke, Howard Burris, Justin Gainor, Martin Gutierrez, Daniel Cho, Ricklie Julian, Pamela Cohen, Joshua Frederick, Celine Robert-Tissot, Honghong Zhou, Kinjal Mody, Karen Keating, Robert Meehan

In vivo evaluation of complex polyps with endoscopic optical coherence tomography and deep learning during routine colonoscopy: a feasibility study by Haolin Nie, Hongbo Luo, Vladimir Lamm, Shuying Li, Sanskar Thakur, Chao Zhou, Thomas Hollander, Daniel Cho, Erika Sloan, Jingxia Liu, Pooja Navale, Ahmad N. Bazarbashi, Juan Pablo Reyes Genere, Vladimir M. Kushnir, Quing Zhu

Get full text

420 Progression-free survival and biomarker correlates of response with BEMPEG plus NIVO in previously untreated patients with metastatic melanoma: results from the PIVOT-02 study... by Mario Sznol, Adi Diab, Brendan Curti, Igor Puzanov, Gregory Daniels, Jonathan Zalevsky, Ute Hoch, Mary Tagliaferri, Michael Hurwitz, Scott Tykodi, Michele Maio, Sekwon Jang, Tuan Nguyen, Wei Lin, Karl Lewis, Alexander Spira, Ewa Kalinka, Daniel Cho, Shanhong Guan, Erika Puente, Sue Currie

516 Peripheral and tumoral immune activity in the expansion part of the first-in-human DuoBody®-PD-L1×4–1BB (GEN1046) trial by Andrés Cervantes, Victor Moreno, Maria Jure-Kunkel, Suresh Ramalingam, Emiliano Calvo, Patricia LoRusso, Brandon Higgs, Suzana Couto, Nora Pencheva, Santiago Ponce Aix, Daniel Cho, Alexander Muik, Özlem Türeci, Tahamtan Ahmadi, Ugur Sahin, Elena Garralda, Ulf Forssmann, Eleni Lagkadinou, José Trigo Pérez, Muhammad Furqan